Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Biotechs on the Brink Choose Last-Minute Deals, Not Liquidation

This article was originally published in Start Up

Executive Summary

Many biotechs, facing crisis situations in the fall of 2002, opted for deals that kept them alive but hardly offered much hope for upside. But in the coming months, boards may need to be far more realistic about their long-term prospects and consider a full range of options, including liquidation, when assessing a company's future.
Advertisement

Related Content

Leading a Biotech Through Crisis
CAT Chooses OGS for its Dowry
Antisoma Takes Refuge With Roche
GPC/NeoTherapeutics: Winners and Losers
GPC/NeoTherapeutics: Winners and Losers
Biotech Layoffs Hit Hardest In Discovery
UK Biotech Learns the Hard Way
Genomica Gives Up the Ghost
Idec Eyes Success
Idec Eyes Success

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

SC090665

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel